This site is intended for health professionals only

Published on 10 July 2014

Share this story:
Twitter
LinkedIn

Insight e-Zine focuses on pharmaceutical industry

RepRisk has released the sixth edition of its Insight e-Zine, which focuses on environmental, social and governance (ESG) matters specific to the pharmaceutical industry.

Pharmaceutical companies hold a vast amount of power and, arguably, responsibility, due to the impact they have on people’s lives. The complexity of balancing this unique position with the necessity to maintain a profitable business has produced some interesting ethical challenges.

RepRisk has released the sixth edition of its Insight e-Zine, which focuses on environmental, social and governance (ESG) matters specific to the pharmaceutical industry.

Pharmaceutical companies hold a vast amount of power and, arguably, responsibility, due to the impact they have on people’s lives. The complexity of balancing this unique position with the necessity to maintain a profitable business has produced some interesting ethical challenges.

The corresponding ESG concerns are analysed and discussed in this issue of Insight from a range of corporate, NGO and academic perspectives.

The articles cover global issues such as the ethics of clinical trials in developing countries, misleading marketing of drugs, access to medicines, balancing profitability with patient protection, water security risks, anti-competition and bribery, and more.

Click here to read the e-Zine: RepRisk Insight #6



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn